MedTrace Logo

Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination

NCT04832022 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 397

Last updated 2023-08-14

No results posted yet for this study

Summary

To date, studies on SARS-CoV2and vaccines have been mostly from the general population not exposed to immunosuppressants. The efficacy and safety of COVID-19 vaccines need to be evaluated in these populations.

Conditions

  • Rheumatic Diseases
  • SARS-CoV Infection
  • COVID-19

Interventions

OTHER

Biological samples

Serum and plasma samples. At baseline, 3, 6 and 12 months

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-07
Primary Completion
2022-06-21
Completion
2023-06-27

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04832022 on ClinicalTrials.gov